These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 21677840)

  • 1. Lower body weight and female gender: hyperphosphatemia risk factors after sodium phosphate preparations.
    Deepak P; Ehrenpreis ED
    World J Gastroenterol; 2011 Jun; 17(21):2681-2. PubMed ID: 21677840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperphosphatemia after sodium phosphate laxatives in low risk patients: prospective study.
    Casais MN; Rosa-Diez G; Pérez S; Mansilla EN; Bravo S; Bonofiglio FC
    World J Gastroenterol; 2009 Dec; 15(47):5960-5. PubMed ID: 20014460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased serum phosphate levels and calcium fluxes are seen in smaller individuals after a single dose of sodium phosphate colon cleansing solution: a pharmacokinetic analysis.
    Ehrenpreis ED
    Aliment Pharmacol Ther; 2009 Jun; 29(11):1202-11. PubMed ID: 19298584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severe hyperphosphatemia after oral laxative administration in a 7-year-old patient.
    Ödek Ç; Kendirli T; Yaman A; Kurt-Şükür ED; Telli O; Burgu B; Özçakar ZB
    Turk J Pediatr; 2016; 58(1):116-118. PubMed ID: 27922249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Massive hyperphosphatemia in a patient with neuronal intestinal dysplasia after bowel preparation with oral sodium phosphate.
    Arikan H; Guler D; Birdal G; Nalcaci S; Aykut E; Ozcan C; Irmak R; Banzragch M; Arzu V
    Ren Fail; 2013 Jul; 35(6):875-8. PubMed ID: 23713794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severe hyperphosphatemia after administration of sodium-phosphate containing laxatives in children: case series and systematic review of literature.
    Ladenhauf HN; Stundner O; Spreitzhofer F; Deluggi S
    Pediatr Surg Int; 2012 Aug; 28(8):805-14. PubMed ID: 22820833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal risks of sodium phosphate tablets for colonoscopy preparation: a review of adverse drug reactions reported to the US Food and Drug Administration.
    Ehrenpreis ED; Parakkal D; Semer R; Du H
    Colorectal Dis; 2011 Sep; 13(9):e270-5. PubMed ID: 21689347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Severe hyperphosphatemia induced by a phosphate-containing oral laxative.
    Filho AJ; Lassman MN
    Ann Pharmacother; 1996 Feb; 30(2):141-3. PubMed ID: 8835046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Age as a predictor of hyperphosphatemia after oral phosphosoda administration for colon preparation.
    Gumurdulu Y; Serin E; Ozer B; Gokcel A; Boyacioglu S
    J Gastroenterol Hepatol; 2004 Jan; 19(1):68-72. PubMed ID: 14675245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Acute phosphate nephropathy secondary to the use of oral sodium phosphate laxatives. Report of one case].
    Ávila E; Purto D; Kutscher S; Cornejo C; Severino N; Méndez GP; Tagle R
    Rev Med Chil; 2021 Jun; 149(6):934-938. PubMed ID: 34751354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperphosphatemia, hypocalcemia and increased serum potassium concentration as distinctive features of early hypomagnesemia in magnesium-deprived mice.
    Ortega B; MacWilliams JR; Dey JM; Courtright VB
    Magnes Res; 2015 Dec; 28(4):126-35. PubMed ID: 26878252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Acute hyperphosphatemia in a dialysis patient after administration of sodium phosphate].
    Azad BB; Cordtz J
    Ugeskr Laeger; 2009 Apr; 171(17):1414. PubMed ID: 19413942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intermediate bioelectrolyte changes after phospho-soda or polyethylene glycol precolonoscopic laxatives in a population undergoing health examinations.
    Kan WC; Wang HY; Chien CC; Tan CK; Lin CY; Su SB
    Nephrol Dial Transplant; 2012 Feb; 27(2):752-7. PubMed ID: 21617195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measurement of serum electrolytes and phosphate after sodium phosphate colonoscopy bowel preparation: an evaluation.
    Ainley EJ; Winwood PJ; Begley JP
    Dig Dis Sci; 2005 Jul; 50(7):1319-23. PubMed ID: 16047480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fatal iatrogenic hyperphosphatemia.
    Kosseifi S; Nassour D; Byrd RP; Roy TM
    J Ky Med Assoc; 2008 Sep; 106(9):431-4. PubMed ID: 18828334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Is the preparation with sodium phosphate purgative for bowel cleansing safe in low-risk patients?].
    Casais M; Rosa Diez G; Bravo S; Mansilla EN; Pérez S; Petkoff B; De Paula JA; Dávolos J; Algranati S; Vaccaro C; Bonofiglio FC
    Acta Gastroenterol Latinoam; 2010 Mar; 40(1):54-60. PubMed ID: 20446397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical aspect of recent progress in phosphate metabolism. Hyperphosphatemia and hypophosphatemia].
    Michigami T
    Clin Calcium; 2009 Jun; 19(6):785-92. PubMed ID: 19483272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum electrolyte shifts following administration of sodium phosphates enema.
    Jacobson RM; Peery J; Thompson WO; Kanapka JA; Caswell M
    Gastroenterol Nurs; 2010; 33(3):191-201. PubMed ID: 20531106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severe hyperphosphatemia following phosphate administration for bowel preparation in patients with renal failure: two cases and a review of the literature.
    Fine A; Patterson J
    Am J Kidney Dis; 1997 Jan; 29(1):103-5. PubMed ID: 9002537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.